Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-ά production

Blood

Volumn 111, Issue 8, 2008, Pages 4245-4253

  Meyer Wentrup, Friederike ^a   Benitez Ribas, Daniel ^a   Tacken, Paul J ^a   Punt, Cornells J A ^a   Figdor, Carl G ^a   De Vries, I Jolanda M ^a   Adema, Gosse J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; C TYPE LECTIN RECEPTOR; CLATHRIN; DENDRITIC CELL IMMUNORECEPTOR; LECTIN RECEPTOR; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; CLEC4A PROTEIN, HUMAN; HEMOCYANIN; IMMUNOGLOBULIN RECEPTOR; INTERFERON; KEYHOLE LIMPET HEMOCYANIN; KEYHOLE-LIMPET HEMOCYANIN; LECTIN; MEMBRANE PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CHO CELL; CRICETULUS; CYTOLOGY; ENDOCYTOSIS; HAMSTER; IMMUNOLOGY; LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL LINE; CHO CELLS; CLATHRIN; CRICETINAE; CRICETULUS; DENDRITIC CELLS; ENDOCYTOSIS; HEMOCYANIN; HUMANS; INTERFERON TYPE I; LECTINS, C-TYPE; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 9;

EID: 43249130188     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-03-081398     Document Type: Article

References (46)

1. Figdor CG, van Kooyk Y, Adema GJ. G-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol. 2002;2:77-84.
2. Cambi A, Koopman M, Figdor CG. How C-type lectins detect pathogens. Cell Microbiol. 2005;7:481-488.
3. Akira S, Hemmi H. Recognition of pathogen-ssociated molecular patterns by TLR family. Immunol Lett. 2003:85:85-95.
4. Dudziak D, Kamphorst AO, Heidkamp GF, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315:107-111.
5. Tacken PJ, de Vries I J, Gijzen K, et al. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood. 2005; 106:1278-1285.
6. Bozzacco L, Trumpfheller C, Siegal FP, et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci USA. 2007;104:1289-1294.
7. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004;5:1219-1226.
8. Cao W, Liu YJ. Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol. 2007;19:24-30.
9. Vissers JL, Hartgers FC, Lindhout E, Teunissen MB, Figdor CG, Adema GJ. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J Leukoc Biol. 2001 ;69:785-793.
10. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001 ;194:863-869.
11. Garcia-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in detente. Science. 2006;312:879-882.
12. SchlechtG, Garcia S, EscriouN, FreitasAA, Leclerc C, Dadaglio G. Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation. Blood. 2004;104:1808-1815.
13. Means TK, Latz E, Hayashi F Murali MR, Golen-bock DT, Luster AD. Human lupus autoanti-bodyDNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest. 2005;115:407-417.
14. Benitez-Ribas D, Adema GJ, Winkels G, et al. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma Rll-mediated uptake. J Exp Med. 2006;203:1629-1635.
15. Dzionek A, SohmaY, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type 11 C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001;194:1823-1834.
16. Chen CH, Floyd H, Olson NE, etal. Dendritic-cellassociated C-type lectin 2 (DGAL-2) alters dendritic-cell maturation and cytokine production. Blood. 2006;107:1459-1467.
17. Bates EE, Fournier N, Garcia E, et al. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptortyrosine-based inhibitory motif. J Immunol. 1999;163:1973-1983.
18. Kanazawa N, Okazaki T, Nishimura H, Tashiro K, Inaba K, Miyachi Y. DGIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif. J Invest Dermatol. 2002;118:261-266.
19. Heuser JE, Anderson RG. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Gell Biol. 1989; 108:389-400.
20. Daukas G, Zigmond SH. Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes. J Gell Biol. 1985;101: 1673-1679.
21. de Vries IJ, Lesterhuis WJ, Scharenborg NM, et al. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin Cancer Res. 2003;9: 5091-5100.
22. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165:6037-6046.
23. Liu YJIPC: professional type 1 interferon- producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005;23:275- 306.
24. ItoT KanzlerH, Duramad O, CaoW, Liu YJ. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood. 2006;107:2423-2431.
25. Bennett SR, Carbone FR, Karamalis F, Ravel I RA, Miller JE Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 1998;393:478-480.
26. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol. 2005;23:515-548.
27. Richard M, Thibault N, Veilleux P, Gareau-Page G, Beaulieu AD. Granulocyte macrophage-colony stimulating factor reduces the affinity of SHP-2 for the ITIM of CLECSF6 in neutrophils: a new mechanism of action for SHP-2. Mol Immunol. 2006;43:1716-1721.
28. Coggeshall KM, Nakamura K, Phee H. How do inhibitory phosphatases work? Mol Immunol. 2002;39:521-529.
29. Boonstra A, Rajsbaum R, Holman M, etal. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependentTLR signals, and TLR-independent signals. J Immunol. 2006;177:7551-7558.
30. Bauer M, Redecke V, Ellwart JW, et al. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123 + dendritic cells. J Immunol. 2001 ;166:5000-5007.
31. Perrais D, Merrifield CJ. Dynamics of endocytic vesicle creation. Dev Cell. 2005:9:581-592.
32. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with inter- leukin (IL)-3 and CD40-ligand. J Exp Med. 1997; 185:1101-1111.
33. Asselin-Paturel C, Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med. 2005;202:461-465.
34. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13:816-825.
35. Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med. 2002;195:1653-1659.
36. Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol. 2006;6:33-43.
37. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor2. J Exp Med. 2003;197:1107-1117.
38. Meyer-Wentrup F, Figdor CG. Ansems M, et al. Dectin-1 interaction with tetraspanin CD37 inhibits IL-6 production. J Immunol. 2007;178:154- 162.
39. GeijtenbeekTB, Van Vliet SJ, Koppel EA, et al. Mycobacteria target DG-SIGN to suppress dendritic cell function. J Exp Med. 2003;197:7-17.
40. Le Roy C, Wrana JL. Clathrin- and non-clathrin- mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol. 2005;6:112-126.
41. Tacken PJ, Torensma R, Figdor CG. Targeting antigens to dendritic cells in vivo. Imrnunobiology. 2006;211:599-608.
42. Gilliet M, Kleinhans M, Lantelme E, Schadendorf D, Burg G, Nestle FO. Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neo- antigen. Blood. 2003;102:36-42.
43. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev. 2005;207:166-183.
44. Kuchtey J, Chefalo PJ, Gray RC, Ramachandra L, Harding CV. Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. J Immunol. 2005;175:2244-2251.
45. Gray RC, Kuchtey J, Harding CV. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross- presentation in DCs as effectively as CpG-Aand CpG-C ODNs. J Leukoc Biol. 2007;81:1075- 1085.
46. LeBon A, Etchart N, Rossmann C, etal. Cross- priming of CD8+ T cells stimulated by virus- induced type I interferon. Nat Immunol. 2003;4: 1009-1015.